183 related articles for article (PubMed ID: 23909028)
1. [Endocrinology of breast cancer as a heterogeneous disease: a decade after the millennium].
Bershteĭn LM
Vopr Onkol; 2013; 59(3):292-8. PubMed ID: 23909028
[No Abstract] [Full Text] [Related]
2. Molecular oncology and the neoadjuvant setting: the perfect blend for treatment personalization and clinical trial design.
Generali D; Berruti A; Foroni C; Bazzola L; Andreis D; Allevi G; Bersiga A; Dogliotti L; Fox SB; Harris AL; Bottini A
J Natl Cancer Inst Monogr; 2011; 2011(43):67-70. PubMed ID: 22043044
[TBL] [Abstract][Full Text] [Related]
3. Search for new treatments intensifies for triple-negative breast cancer.
Brower V
J Natl Cancer Inst; 2009 Nov; 101(22):1536-7. PubMed ID: 19880812
[No Abstract] [Full Text] [Related]
4. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.
Tsutsumi Y
Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930
[TBL] [Abstract][Full Text] [Related]
5. [Gene expression analysis and its clinical use in breast tumors].
Semiglazov VF; Semiglazov VV; Moiseenko FV; Bogdanov AA; Boĭtsov VV; Viaz'min SV; Gorab DN; Chubenko VA; Brezhnev NV; Luk'ianchikova VS; Dubina MV
Vopr Onkol; 2013; 59(1):25-9. PubMed ID: 23805447
[No Abstract] [Full Text] [Related]
6. [Triple-negative breast carcinoma--rewiev of current literature].
Rubovszky G; Udvarhelyi N; Horváth Z; Láng I; Kásler M
Magy Onkol; 2010 Dec; 54(4):325-35. PubMed ID: 21163763
[TBL] [Abstract][Full Text] [Related]
7. Novel targets for triple-negative breast cancer.
Carey LA
Clin Adv Hematol Oncol; 2011 Sep; 9(9):678-80. PubMed ID: 22402512
[No Abstract] [Full Text] [Related]
8. What is triple-negative breast cancer?
Irvin WJ; Carey LA
Eur J Cancer; 2008 Dec; 44(18):2799-805. PubMed ID: 19008097
[TBL] [Abstract][Full Text] [Related]
9. Triple-negative/basal-like breast cancer: clinical, pathologic and molecular features.
Venkitaraman R
Expert Rev Anticancer Ther; 2010 Feb; 10(2):199-207. PubMed ID: 20131996
[TBL] [Abstract][Full Text] [Related]
10. [Basal subtype of breast cancer--a unit of specific characteristics of immunophenotyping?].
Niemiec J; Ryś J
Pol J Pathol; 2011 Dec; 62(4 Suppl 4):s36-44. PubMed ID: 22693732
[No Abstract] [Full Text] [Related]
11. A lower Allred score for progesterone receptor is strongly associated with a higher recurrence score of 21-gene assay in breast cancer.
Tang P; Wang J; Hicks DG; Wang X; Schiffhauer L; McMahon L; Yang Q; Shayne M; Huston A; Skinner KA; Griggs J; Lyman G
Cancer Invest; 2010 Nov; 28(9):978-82. PubMed ID: 20690804
[TBL] [Abstract][Full Text] [Related]
12. Decreased androgen receptor expression is associated with distant metastases in patients with androgen receptor-expressing triple-negative breast carcinoma.
Sutton LM; Cao D; Sarode V; Molberg KH; Torgbe K; Haley B; Peng Y
Am J Clin Pathol; 2012 Oct; 138(4):511-6. PubMed ID: 23010705
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA signatures: clinical biomarkers for the diagnosis and treatment of breast cancer.
Andorfer CA; Necela BM; Thompson EA; Perez EA
Trends Mol Med; 2011 Jun; 17(6):313-9. PubMed ID: 21376668
[TBL] [Abstract][Full Text] [Related]
14. Triple-negative breast cancer.
Oncology (Williston Park); 2010 Oct; 24(10 Suppl):40a. PubMed ID: 21275325
[No Abstract] [Full Text] [Related]
15. Triple-negative breast cancer: what the radiologist needs to know.
Whitman GJ; Albarracin CT; Gonzalez-Angulo AM
Semin Roentgenol; 2011 Jan; 46(1):26-39. PubMed ID: 21134526
[No Abstract] [Full Text] [Related]
16. Receptor-based predictors of response in breast cancer.
McGovern UB; Stebbing J
Future Oncol; 2009 Apr; 5(3):283-6. PubMed ID: 19374534
[No Abstract] [Full Text] [Related]
17. Does androgen receptor have a prognostic role in patients with estrogen/progesterone-negative and c-erbB-2-positive breast cancer?
Arslan C; Isik M; Guler G; Kulac I; Solak M; Turker B; Ozisik Y; Altundag K
Am Surg; 2012 Sep; 78(9):992-9. PubMed ID: 22964210
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic targets in triple negative breast cancer.
O'Toole SA; Beith JM; Millar EK; West R; McLean A; Cazet A; Swarbrick A; Oakes SR
J Clin Pathol; 2013 Jun; 66(6):530-42. PubMed ID: 23436929
[TBL] [Abstract][Full Text] [Related]
19. Is triple negative a prognostic factor in breast cancer?
Nishimura R; Arima N
Breast Cancer; 2008; 15(4):303-8. PubMed ID: 18369692
[TBL] [Abstract][Full Text] [Related]
20. Expression of nuclear receptor DAX-1 and androgen receptor in human breast cancer.
Chae BJ; Lee A; Bae JS; Song BJ; Jung SS
J Surg Oncol; 2011 Jun; 103(8):768-72. PubMed ID: 21240988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
